Inventor · disambiguated record
Joseph Hedrick
Also filed as: HEDRICK JOSEPH · HEDRICK JOSEPH A
19 granted patents·9 pending applications·102 citations·filing 1997–2019
93Inventor score
Files withSCHERING CORP16JANSSEN BIOTECH INC3SCHERING CORP CANJI INC2HEDRICK JOSEPH A1MERCK SHARP & DOHME1
Top patents by PatentIndex Score
28 records- 0192US8598320B2Anti-PCSK9 and methods for treating lipid and cholesterol disordersHEDRICK JOSEPH A·Filed 2008·Granted Dec 3, 2013·52 cites·9 claims
- 0282US9089522B2Method of reducing total cholesterol level by administering matrilin-2 polypeptideZHANG QING·Filed 2009·Granted Jul 28, 2015·2 cites·18 claims
- 0381US10465003B2Anti-TNF antibodies, compositions, methods and use for the treatment or prevention of type 1 diabetesJANSSEN BIOTECH INC·Filed 2017·Granted Nov 5, 2019·6 cites·6 claims
- 0478US6613533B2Histamine receptorSCHERING CORP·Filed 2001·Granted Sep 2, 2003·4 cites·6 claims
- 0577US7101987B2CCL27 polypeptidesSCHERING CORP·Filed 2002·Granted Sep 5, 2006·6 cites·9 claims
- 0675US6737252B27 transmembrane receptor family member BLRXSCHERING CORP·Filed 2001·Granted May 18, 2004·4 cites·16 claims
- 0775US2010068763A1Mammalian chemokines; receptors; reagents; usesSCHERING CORP CANJI INC·Filed 2009·Application pending·0 cites
- 0870US7157244B2Adenosine receptorSCHERING CORP·Filed 2001·Granted Jan 2, 2007·2 cites·28 claims
- 0970US2008107643A1Mammalian chemokines; receptors; reagents; usesSCHERING CORP CANJI INC·Filed 2007·Application pending·0 cites
- 1066US7307146B2Dnaxccr10SCHERING CORP·Filed 2006·Granted Dec 11, 2007·0 cites·7 claims
- 1166US6204017B1Polynucleotide encoding a histamine receptorSCHERING CORP·Filed 1999·Granted Mar 20, 2001·21 cites·20 claims
- 1263US11124565B2Method for treating pre-type 1 diabetes in a human subjectJANSSEN BIOTECH INC·Filed 2019·Granted Sep 21, 2021·0 cites·8 claims
- 1362US8119786B2Nucleic acids encoding CCL27VICARI ALAIN·Filed 2009·Granted Feb 21, 2012·0 cites·11 claims
- 1462US2004203080A17 transmembrane receptor family member BLRxFiled 2004·Application pending·0 cites
- 1560US7601815B2Anti-CCL27 antibodiesSCHERING CORP·Filed 2006·Granted Oct 13, 2009·0 cites·22 claims
- 1659US7465789B2Adenosine receptorSCHERING CORP·Filed 2006·Granted Dec 16, 2008·0 cites·4 claims
- 1759US6416954B1Modulating Th2 cell levels via vMIP-I/CCR8 interactionSCHERING CORP·Filed 2000·Granted Jul 9, 2002·2 cites·6 claims
- 1855US7547523B2Histamine receptorSCHERING CORP·Filed 2007·Granted Jun 16, 2009·0 cites·2 claims
- 1953US2003007970A1Lymphotactin usesSCHERING CORP·Filed 2002·Application pending·0 cites
- 2051US7205381B2Mammalian cytokines; related reagents and methodsSCHERING CORP·Filed 2001·Granted Apr 17, 2007·0 cites·10 claims
- 2150US2014161798A1Anti-pcsk9 and methods for treating lipid and cholesterol disordersMERCK SHARP & DOHME·Filed 2013·Application pending·0 cites
- 2250US2019092849A1Anti-tnf antibodies, compositions, methods and use for the treatment or prevention of type 1 diabetesJANSSEN BIOTECH INC·Filed 2017·Application pending·0 cites
- 2349US7166705B2Histamine receptor antibodySCHERING CORP·Filed 2003·Granted Jan 23, 2007·0 cites·13 claims
- 2448US2004097482A1Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indicationsSCHERING CORP·Filed 2003·Application pending·0 cites
- 2546US2002172681A1Modulating Th2 cell levels via vMIP-I/CCR8 interactionFiled 2002·Application pending·0 cites
- 2637US6022534ALymphotactin usesSCHERING CORP·Filed 1997·Granted Feb 8, 2000·3 cites·9 claims
- 2731US2002103361A1Mammalian chemokines; receptors; reagents; usesFiled 2001·Application pending·0 cites
- 2830US6395268B1Lymphotactin usesSCHERING CORP·Filed 1999·Granted May 28, 2002·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Joseph Hedrick files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →